bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.02.16.706181

Four Core Genotypes Mice Exhibit Quantitative Differences in T and B Cell Subpopulations compared to Wild-type Mice.

Abstract

It has been well established that females have a more active immune system. Females respond better to vaccines, are more resistant to somatic cell cancers, display better pathogen responses, present antigens better, and, conversely, are more prone to autoimmune diseases compared to male counterparts. Though these trends have been observed across normal and pathogenic states, the mechanisms underlying these sex differences have not been fully explained. Some hormonal effects on immune cell populations have been reported, but much less is known about effects contributed by genes on the sex chromosomes, for example those that are more highly expressed in females due to X inactivation escape, or Y-linked genes those unique to males. Here we use the Four Core Genotypes (FCG) mouse model and wildtype XY male mice to disentangle the effects of sex hormones, sex chromosome complement, and their interactions on baseline B and T cell populations in the periphery and T cells in the thymus. We test the effects of a previously described X-Y chromosomal translocation and those of the Sry transgene insertion on chromosome 3. We observe that mice harboring the Sry transgene show significant depletion of peripheral CD8+ T cell subpopulations. In the thymus, the XY XY,but not the XX males, show significant decrease to both CD8+ and CD4+ single positive T cells and an increase to CD4/CD8 double positive T cells. We also show that Y chromosome-bearing mice exhibit depletion in splenic marginal zone B cells. Our data suggests that the gonadal sex is the strongest contributor to this phenotype. Our studies define a critical framework for the use of this model and provide valuable data to assess the use of the FCGs model, especially for diseases involving the immune response.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

McGuire, G. R., Klimas, A. S., Deegan, D. F., Calendo, G., Alapatt, C., Zaidi, M. R. R., Bottaro, A., Engel, N.. 2026-02-18. Four Core Genotypes Mice Exhibit Quantitative Differences in T and B Cell Subpopulations compared to Wild-type Mice.. https://doi.org/10.64898/2026.02.16.706181

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ksp37 is a rapidly mobilized NK cell secretory protein that engages FGF2

A key feature of natural killer (NK) cells is their preloaded arsenal of effector molecules, allowing them to rapidly respond upon activation. In this study, we characterized a previously unexplored secretory protein, termed killer-specific secretory protein of 37 kDa (Ksp37), which is highly abundant in differentiated CD56dim NK cells. Ksp37 is rapidly secreted in a dose-dependent and JAK-1 dependent manner upon low levels of cytokine stimulation, making it a sensitive readout for NK cell activation. Following secretion, intracellular levels were rapidly replenished, preserving responsiveness to subsequent cytokine stimulation. We found that Ksp37 is stored in polarized intracellular compartments distinct from those containing canonical cytotoxic effector molecules, including granzyme B and perforin, which require stronger stimulation for release. Lastly, we identified Ksp37 as a novel binding partner of fibroblast growth factor 2 (FGF2). This opens new avenues of exploration for the role of NK cells in remodeling their extracellular environment by modulating the FGF2-FGFR1 axis, which plays a key role in tumor growth, angiogenesis and tissue repair.

immunology↗

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗